ABOUT US
Who We Are
Founded in 2019, Pellucid Pharma was built on a clear belief:
API sourcing should be a strategic advantage — not an operational burden.
In an industry where regulatory scrutiny is unforgiving and supply disruptions can derail entire product lifecycles, we set out to create a different kind of API sourcing partner — one that blends technical depth, regulatory awareness, and commercial discipline.
We act as an extension of your procurement, quality, and regulatory teams, navigating the complexity of the Indian manufacturing ecosystem to deliver APIs that meet global expectations for consistency, compliance, and reliability. Our focus is not just on supplying material, but on strengthening the integrity of your entire supply chain.
Built for Global Pharmaceutical Realities
Export-focused pharmaceutical companies operate under intense pressure — tight timelines, evolving regulations, and zero margin for quality failures. We understand that every API decision has downstream consequences for filings, audits, and market access.
That’s why our approach is grounded in risk awareness, lifecycle thinking, and long-term sustainability. From early development stages through commercial supply, we help our partners make sourcing decisions that stand up to regulatory review and commercial scale.
The Pellucid Edge: We Understand Your Real Challenges
Pharmaceutical sourcing operates under tight margins and zero tolerance for failure. Our strength lies in addressing the realities that matter most — not just on paper, but in day-to-day operations:
By addressing these challenges holistically, we help our partners avoid costly delays, regulatory queries, and last-minute firefighting.
Our Partnership Philosophy
We go beyond transactional buying and selling.
By maintaining long-term relationships with qualified manufacturers and applying structured risk-management practices, we help our partners build future-ready API supply chains. Every manufacturer relationship is evaluated not only on price, but on quality culture, regulatory history, scalability, and responsiveness.
Our partnerships are built on alignment — technical, commercial, and ethical. We believe that transparent communication, early problem identification, and shared accountability are essential to long-term success in regulated markets.
When you work with Pellucid Pharma, you gain more than a sourcing agent —
you gain a partner focused on long-term growth, regulatory confidence, and operational peace of mind.
Why Clients Choose Pellucid Pharma
Because in global pharmaceuticals, reliability is not optional — it’s foundational.
Our clients choose us for our ability to anticipate risks, simplify complexity, and deliver consistency across borders and product lifecycles.
We don’t just supply APIs. We help protect your approvals, your timelines, and your reputation.
ALPEX PHARMA IS A TECHNOLOGY COMPANY PELLUCID PHARMA IS A TECHNOLOGY COMPANY WITH EXPERTISE IN DRUG DEVELOPMENT & DELIVERY SOLUTIONS THAT RELEASE THE TRUE VALUE OF ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)
STRONG LEADERSHIP TEAM
Alpex Pharma is led by a seasoned team of executives who bring a collective and Pellucid Pharma is led by a seasoned team of executives who bring a collective and deep understanding of the international pharmaceutical industry. Our management has proven abilities in delivering industry-leading growth and operational performance.
KEVIN MCKENZIE
Shareholder, Chairman & President
Kevin graduated with an MBA from Wharton Business School. He has over 20 years of global private equity experience in top notch firms including Cerberus Capital Management, Morgan Stanley Private Equity, and multinational pharma and biotech company top leadership roles. He is Fluent in Chinese, French, Italian, German (B1). McKenzie is a Canadian Citizen with Switzerland permanent resident status based in Switzerland.
SHAHBAZ ARDALAN
Managing Director
Shahbaz has over 40 years of pharma experience, including 25 years managing Alpex Pharma. He has vast knowledge of Pharma solid dosage formulation R&D technology with 100 registered global patents under his leadership. Shahbaz is well-connected with global distributors to leading pharma companies. Fluent in Italian and French. Shahbaz is a Swiss citizen based in Switzerland.
GABRIELE GRANATA
DEVELOPMENT MANAGER, R&D
Gabriele is a seasoned chemist with more than 25 years of experience in formulation, analytical method validation, IP creation, GLP and FDA regulations. Granata developed and patented controlled substances and narcotics for the US & worldwide markets, such as Phentermine and Fentanyl Buccal tablets. Granata is fluent in Italian and English having his residency in Switzerland.
ALLA TULUKTORAMAN
FINANCIAL CONTROLLER
Tuluktoraman holds a diploma in Economics with decades of professional experience in finance, accounting, and financial administration, having started in auditing and tax consulting. She worked for global companies managing different markets and industries. She is ACCA UK qualified with fluency in Italian, German, and English. She is a Swiss citizen having her main residence based in Switzerland.